Merus NV
NASDAQ:MRUS
Merus NV
Cash from Financing Activities
Merus NV
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Merus NV
NASDAQ:MRUS
|
Cash from Financing Activities
$230.1m
|
CAGR 3-Years
80%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Cash from Financing Activities
-$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Cash from Financing Activities
-€2.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Cash from Financing Activities
$362.7m
|
CAGR 3-Years
266%
|
CAGR 5-Years
18%
|
CAGR 10-Years
23%
|
|
argenx SE
XBRU:ARGX
|
Cash from Financing Activities
$1.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Cash from Financing Activities
€375.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Merus NV's Cash from Financing Activities?
Cash from Financing Activities
230.1m
USD
Based on the financial report for Dec 31, 2023, Merus NV's Cash from Financing Activities amounts to 230.1m USD.
What is Merus NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
30%
Over the last year, the Cash from Financing Activities growth was 292%. The average annual Cash from Financing Activities growth rates for Merus NV have been 80% over the past three years , 30% over the past five years .